Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001104659-20-133638

Options or other derivatives

  • Chief Financial Officer acquired 23,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Martin Steven Robert Chief Financial Officer 2020-12-08 Grant or award · Stock Option (Right to Buy) +23,000 23,000 D: show line 1 in the form
Loading xslF345X03/tm2038059-6_4seq1.xml…